From January 1, 2022 to March 23, 2022, the company has repurchased 240,000 shares, representing 0.84% for ¥255.53 million. With this, the company has completed the repurchase of 300,000 shares, representing 1.06% for ¥316.48 million under the buyback announced on July 12, 2021.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,310 JPY | -1.32% | +10.13% | +29.76% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.76% | 443M | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- 4886 Stock
- News ASKA Pharmaceutical Holdings Co.,Ltd.
- Tranche Update on ASKA Pharmaceutical Holdings Co.,Ltd.'s Equity Buyback Plan announced on July 12, 2021.